Related Experiment Videos
[Use of the internal thoracic artery in repeat myocardial revascularization surgery]
M Perić1, S Nastasić, M Jakovljević
1Institut za kardiovaskularne bolesti Dedinje, Beograd.
Insights
Redo myocardial revascularization is rising, posing higher risks. However, using internal thoracic artery grafts did not significantly increase mortality or morbidity compared to vein grafts alone.
Area of Science:
- Cardiovascular Surgery
- Cardiac Surgery Outcomes
- Myocardial Revascularization
Background:
- Redo myocardial revascularization procedures are becoming more frequent.
- These repeat surgeries carry inherent higher operative risks.
- The impact of internal thoracic artery grafts in redo procedures requires careful evaluation.
Purpose of the Study:
- To assess the outcomes of redo myocardial revascularization.
- To compare the use of internal thoracic artery grafts versus venous grafts in repeat procedures.
- To identify predictors of unfavorable outcomes in redo myocardial revascularization.
Main Methods:
- Retrospective analysis of patients undergoing redo myocardial revascularization.
- Comparison of outcomes between patients receiving internal thoracic artery grafts and those receiving only venous grafts.
- Statistical analysis to determine independent predictors of mortality and morbidity.
Main Results:
- Mortality and morbidity did not significantly differ between internal thoracic artery graft and venous graft groups.
- Independent predictors of unfavorable outcomes included chronic pulmonary disease, age over 65, and NYHA functional class IV.
- Specific predictors varied: age over 65 for the internal thoracic graft group and chronic pulmonary disease for the vein graft group.
Conclusions:
- Internal thoracic artery grafts do not appear to significantly worsen early outcomes in redo myocardial revascularization compared to vein grafts.
- Patient factors like chronic pulmonary disease and advanced age are critical predictors of adverse events.
- Careful consideration of prior graft use is essential when planning repeat revascularization procedures.
Abstract:
The incidence of redo myocardial revascularization is increasing lately. These procedures are accompanied by the higher operative risk, and the use of internal thoracic artery graft may have additional negative impact on early-rization. Mortality and morbidity in this group did not differ significantly compared to a group where only venous grafts were used. Independent predictors of the unfavorable outcome (for both groups) were the presence of the chronic pulmonary disease, age over 65 and NYHA functional class IV. In the group with internal thoracic graft it was the age over 65, while in the group with only vein grafts it was chronic pulmonary disease. We have discussed potential problems during the redo procedure in patients in whom internal thoracic graft was used during the first procedure.